Shanghai Haohai Biological Technology Co., Ltd. (HAOHAI BIOTEC) filed its Monthly Return for Equity Issuer covering the period to 31 August 2026. Key takeaways follow:

1. Registered Share Capital • H shares: 34.78 million units at RMB 1 par value, unchanged during the month. • A shares (Shanghai STAR Market): 194.05 million units at RMB 1 par value, also unchanged. • Total registered share capital remained RMB 228.83 million.

2. Issued Shares and Treasury Position • H shares in issue (excluding treasury): 34.78 million; no treasury stock recorded. • A shares in issue (excluding treasury): 190.20 million with 3.85 million held as treasury shares; no movements during August.

3. Share Repurchase Status • The company previously repurchased 610,000 H shares on 29 May 2026 for cancellation. These shares had not been cancelled as of 31 August 2026; no additional repurchases occurred in August.

4. Public Float Compliance • HAOHAI BIOTEC confirmed that its H share public float continues to meet the Hong Kong Stock Exchange’s minimum 5% requirement for PRC issuers.

No share options, warrants, convertible securities, or other equity-issuing arrangements were outstanding or exercised in the reporting month. The filing was authorised by Joint Company Secretary Tian Min and submitted on 3 September 2026.